Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression

Hepatology Research

Volumn 23, Issue 2, 2002, Pages 115-121

  Ishikawa, Toru ^a   Ichida, Takafumi ^a   Sugahara, Satoshi ^a   Yamagiwa, Satoshi ^a   Matsuda, Yasunobu ^a   Uehara, Kazuhiro ^a   Kato, Takashi ^b   Miyazaki, Hiroshi ^b   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

c Mpl; Liver cirrhosis; Thrombopoietin

Indexed keywords

THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERSPLENISM; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0036626927     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00170-X     Document Type: Article

References (24)

1. Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-8.
2. Shimada Y, Kato T, Ogami K, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995;23:1388-96.
3. Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K. Human platelets display high-affinity receptors for thrombopoietin. Blood 1997;89:1896-904.
4. Fielder PJ, Hass P, Nagel M, et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997;89:2782-8.
5. Kuwaki T, Hagiwara T, Yuki C, Kodama I, Kato T, Miyazaki H. Quantitative analysis of thrombopoietin receptors on human megakaryocytes. FEBS Lett 1998;427:46-50.
6. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c-mp1-mediated binding to platelets. Blood 1996;87:2154-61.
7. Kato T, Oda A, Inagaki Y, et al. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA 1997;94:4669-74.
8. Stefanich E, Senn T, Widmer R, Fratino C, Keller GA, Fielder PJ. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood 1997;89:4063-70.
9. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996;87:567-73.
10. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995;86:3668-75.
11. Ishikawa T, Ichida T, Matsuda Y, et al. Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 1998;13:907-13.
12. Ishikawa T, Ichida T, Matsuda Y, et al. Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis. J Gastroenterol Hepatol 2000;15:647-53.
13. Tanikawa K. Thrombopoietin and liver diseases. J Gastroenterol Hepatol 2000;15:579-80.
14. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
15. Kuter DJ, Rosenberg RD. Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood 1994;84:1464-72.
16. Emmons RV, Reid DM, Cohen RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87:4068-71.
17. Matsumura I, Horikawa Y, Kanakura Y. Functional roles of thrombopoietin-c-mp1 system in essential thrombocythemia. Leuk Lymphoma 1999;32:351-8.
18. Horikawa Y, Matsumura I, Hashimoto K, et al. Markedly reduced expression of platelet c-mp1 receptor in essential thrombocythemia. Blood 1997;90:4031-8.
19. Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998;338:572-80.
20. Kaban K, Kantarjian H, Talpaz M, et al. Expression of thrombopoietin and its receptor (c-mp1) in chronic myelogenous leukemia. Correlation with disease progression and response to therapy. Cancer 2000;88:570-6.
21. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997;89:101-7.
22. Hirayama Y, Sakamaki S, Matsunaga T, et al. Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood 1998;92:46-52.
23. Ericson SG, Gao H, Gericke GH, Lewis LD. The role of polymorphonuclear neutrophils (PMNs) in clearance of granulocyte colony-stimulating factor (G-CSF) in vivo and in vitro. Exp Hematol 1997;25:1313-25.
24. Cardier JE, Dempsey J. Thrombopoietin and its receptor, c-mp1, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood 1998;91:923-9.